Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Contact information


matthew.gardiner@kennedy.ox.ac.uk


Twitter: @mattdgardiner


http://www.rstn.uk

Matthew Gardiner

MA PhD FRCS(Plast)

Honorary Departmental Senior Research Fellow in Plastic and Reconstructive Surgery

  • Consultant Hand and Plastic Surgeon, Frimley Health NHS Foundation Trust
  • Associate Medical Director for Research, Frimley Health NHS Foundation Trust
  • Royal College of Surgeons Surgical Specialty Lead for Hand and Plastic Surgery
  • NIHR Subspecialty Lead for Plastic Surgery and Hands, NIHR LCRN Kent, Surrey, Sussex

Surgical Trials

I co-founded the Reconstructive Surgery Trials Network (RSTN) with Prof. Abhilash Jain in 2013. The RSTN is the UK clinical trials network for plastic surgery and hand surgery. It has over 600 members from undergraduates through to consultants and trials methodologists. 

The RSTN has developed many interdisciplinary collaborations to deliver a diverse range of projects. My main interest is clinical trials relating to hand surgery and in particular developing placebo arm RCTs. Visit rstn.uk for further information. 

Osteoarthritis

As part of the ARUK Centre for OA Pathogenesis, I work with Prof Tonia Vincent on translational projects relating to base of thumb osteoarthritis. This has led to collaborations with groups at University of Leeds (Drs Pete Culmer and Ali Alazmani) and Imperial College London (Dr Angela Kedgley).

MSc Surgical Science and Practice

I am lead for the Health Innovation and Technology module. Further details regarding the course are here.

Background

I read physiological sciences as an undergraduate at Fitzwilliam College, University of Cambridge before moving to Oriel College, University of Oxford to complete my clinical training.

In 2011, I completed a PhD at the Kennedy Institute of Rheumatology, Imperial College London. The aim of the study was to investigate the molecular changes that occur during the initiation and early progression of osteoarthritis (OA).